Curative surgical treatment after inefficient long-acting somatostatin analogues therapy of a tumor-induced osteomalacia.
CHRU de Lille, service d’endocrinologie et des maladies métaboliques, 59037 Lille cedex, France.
Arsene
A
Mékinian
Miriam
M
Ladsous
Anne-Sophie
AS
Balavoine
Bruno
B
Carnaille
Sebastien
S
Aubert
Benoît
B
Soudan
Jean-Louis
JL
Wémeau
D015502:Absorptiometry, Photon; D000369:Aged, 80 and over; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis; D003692:Delayed-Action Preparations; D005260:Female; D005500:Follow-Up Studies; D006393:Hemangiopericytoma / Q000473:pathology / Q000601:surgery*; D006801:Humans; D008441:Maxillary Neoplasms / Q000473:pathology / Q000601:surgery*; D015282:Octreotide / Q000627:therapeutic use; D010018:Osteomalacia / Q000601:surgery*; D010257:Paraneoplastic Syndromes / Q000601:surgery*; D017481:Receptors, Somatostatin / Q000032:analysis; D013004:Somatostatin / Q000031:analogs & derivatives; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal; D014408:Biomarkers, Tumor; D003692:Delayed-Action Preparations; D017481:Receptors, Somatostatin; D013004:Somatostatin; C093733:somatostatin receptor 2; D015282:Octreotide